PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-107.38%
Both yoy net incomes decline, with CRK at -338.49%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
0.99%
D&A growth of 0.99% while CRK is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-125.89%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-98.96%
Negative yoy working capital usage while CRK is 550.33%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-98.96%
Negative yoy usage while CRK is 537.96%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
183.36%
Well above CRK's 38.71%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-30.64%
Negative yoy CFO while CRK is 24.82%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
23.31%
CapEx growth well above CRK's 11.91%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-292.73%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-100.00%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-100.00%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
97.30%
Growth of 97.30% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-44.94%
We reduce yoy invests while CRK stands at 69.44%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.